BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 121410
Published online Oct 27, 2026. doi: 10.4240/wjgs.121410
Table 1 Comparison of baseline characteristics between the two patient groups, mean ± SD
Characteristics
Ineffective group (n = 32)
Effective group (n = 154)
χ2/t value
P value
Sex0.2920.589
    Male18130
    Female14124
Age (year)60.68 ± 4.8161.13 ± 5.040.4780.633
Body mass index (kg/m2)20.88 ± 1.3621.07 ± 1.400.7160.475
Tumor type0.2060.977
    Gastric cancer1154
    Esophageal cancer841
    Colorectal cancer1048
    Other311
Clinical stage0.0100.995
    Stage I942
    Stage II1573
    Stage III839
Hypertension6180.6310.427
Diabetes mellitus5121.1280.288
Nutritional Risk Screening 2002 score4.48 ± 1.054.52 ± 1.100.1940.846
Operative time (minute)252.68 ± 38.48248.69 ± 41.670.5260.599
Table 2 Comparison of serum prealbumin, albumin, and transferrin levels between the two groups, mean ± SD
Group
Parameter
Prior to nutritional support
POD1
POD3
POD7
POD14
F value
P value
Effective group (n = 154)PA (mg/L)231.14 ± 25.84198.41 ± 18.31205.60 ± 20.74234.84 ± 23.67a251.86 ± 23.14a147.478< 0.001
ALB (g/L)38.81 ± 3.0432.12 ± 2.4833.76 ± 2.6339.08 ± 2.92a45.82 ± 3.14a546.320< 0.001
TF (g/L)2.18 ± 0.211.91 ± 0.241.93 ± 0.352.48 ± 0.27a3.10 ± 0.30a484.259< 0.001
Ineffective group (n = 32)PA (mg/L)228.84 ± 26.36195.74 ± 20.63202.60 ± 18.75206.64 ± 18.74210.14 ± 21.6310.773< 0.001
ALB (g/L)38.63 ± 2.8431.92 ± 2.5333.08 ± 2.7036.17 ± 2.4137.08 ± 2.7835.518< 0.001
TF (g/L)2.19 ± 0.201.90 ± 0.241.91 ± 0.262.12 ± 0.302.18 ± 0.299.785< 0.001
Table 3 Comparison of serum C-reactive protein and interleukin-6 levels between the two groups, mean ± SD
Group
Index
Prior to nutritional support
Nutritional support
POD1
Nutritional support POD3
Nutritional support POD7
Nutritional support POD14
F value
P value
Effective group (n = 154)CRP (mg/L)12.93 ± 2.8442.41 ± 3.1538.82 ± 4.2023.47 ± 2.20a14.61 ± 2.12a3166.461< 0.001
IL-6 (pg/mL)13.69 ± 3.1448.85 ± 4.8246.65 ± 4.7528.80 ± 2.73a21.13 ± 2.49a2672.053< 0.001
Ineffective group (n = 32)CRP (mg/L)13.10 ± 2.9641.47 ± 4.5039.40 ± 4.8533.12 ± 3.3630.28 ± 3.60262.806< 0.001
IL-6 (pg/mL)14.08 ± 3.2650.13 ± 5.1547.47 ± 5.6341.76 ± 3.2540.50 ± 3.08371.791< 0.001
Table 4 Comparison of gastrointestinal function recovery between the two groups (day), mean ± SD
Group
First exhaust time
Gastric emptying time
Normal meal times
Hospital length of stay
Effective group (n = 154)2.14 ± 1.518.82 ± 2.4910.40 ± 3.2824.63 ± 2.78
Ineffective group (n = 32)3.08 ± 1.7515.73 ± 2.6014.10 ± 3.3628.75 ± 3.63
t value3.11514.1775.7827.212
P value0.002< 0.001< 0.001< 0.001
Table 5 Predictive power of serum biomarkers on postoperative day 7 for the efficacy rate of parenteral nutrition support
Serum indicators
AUC
Sensitivity (%)
Specificity (%)
P value
SE
95%CI
Serum PA0.67765.6064.300.0120.04640.586-0.768
Serum CRP0.71156.2581.170.0100.05870.596-0.826
Serum PA combined with CRP0.90078.1088.30-0.02940.843-0.958
Table 6 Predictive efficacy of serum markers on postoperative day 14 of nutritional support for the efficacy rate of parenteral nutrition support
Serum indicators
AUC
Sensitivity (%)
Specificity (%)
P value
SE
95%CI
Serum PA0.69875.0072.730.0080.04620.608-0.789
Serum CRP0.72759.3897.400.0060.06470.600-0.854
Serum PA combined with CRP0.95687.5093.50-0.01870.920-0.993


Write to the Help Desk